Optimal Dose of a Cognitive Control Training for Depression Vulnerability
Establishing a Dose-response Relationship for the Effects of a Cognitive Control Training on Depression Vulnerability
1 other identifier
interventional
216
1 country
2
Brief Summary
This study aims to examine the dose-response relationship of an online adaptive cognitive control training on depressive symptomatology and rumination. Participants will be randomized over six groups, each receiving a different dose (0, 1, 5, 10, 15 or 20 sessions) of a cognitive control training in remitted depressed patients. An adaptive Paced Auditory Serial Addition Task will be used as cognitive control training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Feb 2022
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 10, 2021
CompletedFirst Posted
Study publicly available on registry
December 22, 2021
CompletedStudy Start
First participant enrolled
February 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 22, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 22, 2023
CompletedJanuary 3, 2024
January 1, 2024
1.8 years
November 10, 2021
January 2, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Beck Depression Inventory (BDI-II-NL)
Self-report questionnaire with 21 items, depression symptom severity, scores can range from 0 to 63, with higher scores indicating more severe depression.
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Secondary Outcomes (7)
Change in Perseverative Thinking Questionnaire (PTQ-NL)
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Change in Cognitive Emotion Regulation Questionnaire (CERQ)
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Change in Adult Temperament Questionnaire (ATQ), Effortful Control subscale
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Change in Burnout Assessment Tool (BAT)
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Change in Remission from Depression Questionnaire (RDQ-NL)
baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
- +2 more secondary outcomes
Other Outcomes (2)
Change in List of Threatening Experiences (LTE-Q)
3 month follow-up after baseline, 6 month follow-up after baseline
Change in Credibility and Expectancy Questionnaire (CEQ)
baseline, post training (one month after baseline)
Study Arms (2)
Intervention group
EXPERIMENTALCognitive control training: The adaptive Paced Auditory Serial Addition Task (aPASAT) is a Cognitive Control Training where participants need to click on the sum of the last two heard digits. Task difficulty is modified based on the participants' current task performance, allowing training of cognitive control. Five intervention groups will each receive a different amount of sessions.
Control group
NO INTERVENTIONWaitlist control group: Participants randomized to the control group will not perform the cognitive control training during the study, but will be given the opportunity to follow the training afterwards.
Interventions
The five intervention groups will receive either 1, 5, 10, 15 or 20 training sessions with the Adaptive Paced Auditory Serial Addition Task (aPASAT).
Eligibility Criteria
You may qualify if:
- History of ≥ 1 depressive episode(s)
- Currently in remission (≥ 3 months)
- Access to a computer with an internet connection
You may not qualify if:
- Ongoing depressive episode
- Psychotic disorder (current and/or previous)
- Neurological impairments (current and/or previous)
- Excessive substance abuse (current and/or previous)
- Use of antidepressant medication is allowed if kept at a constant level
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Ghentlead
- University Hospital, Ghentcollaborator
- Research Foundation Flanderscollaborator
Study Sites (2)
Ghent University Hospital
Ghent, Oost-Vlaanderen, 9000, Belgium
Ghent University
Ghent, Oost-Vlaanderen, 9000, Belgium
Related Publications (2)
Vander Zwalmen Y, Demeester D, Hoorelbeke K, Verhaeghe N, Baeken C, Koster EHW. The more, the merrier? Establishing a dose-response relationship for the effects of cognitive control training on depressive symptomatology. J Consult Clin Psychol. 2025 Mar;93(3):161-175. doi: 10.1037/ccp0000945.
PMID: 40014506DERIVEDVander Zwalmen Y, Hoorelbeke K, Demeester D, Koster EHW. High-Frequency Cognitive Control Training for Depression: Case Report. JMIR Form Res. 2024 Nov 29;8:e56598. doi: 10.2196/56598.
PMID: 39612206DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ernst Koster, Professor
University Ghent
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 10, 2021
First Posted
December 22, 2021
Study Start
February 1, 2022
Primary Completion
November 22, 2023
Study Completion
November 22, 2023
Last Updated
January 3, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- ANALYTIC CODE
Pseudonymized individual participant data can be stored on Open-Science Framework (OSF).